Michael Glenn Miles - Net Worth and Insider Trading

Michael Glenn Miles Net Worth

The estimated net worth of Michael Glenn Miles is at least $23,050 dollars as of 2024-03-28. Michael Glenn Miles is the CFO of Cancer Genetics Inc and owns about 5,000 shares of Cancer Genetics Inc (CGIX) stock worth over $23,050. Details can be seen in Michael Glenn Miles's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Glenn Miles has not made any transactions after 2019-01-31 and currently still holds the listed stock(s).

Transaction Summary of Michael Glenn Miles

To

Michael Glenn Miles Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Glenn Miles owns 2 companies in total, including Cancer Genetics Inc () , and Vyant Bio Inc () .

Click here to see the complete history of Michael Glenn Miles’s form 4 insider trades.

Insider Ownership Summary of Michael Glenn Miles

Ticker Comapny Transaction Date Type of Owner
Cancer Genetics Inc 2020-01-02 Chief Financial Officer
Vyant Bio Inc 2019-01-31 Chief Financial Officer

Michael Glenn Miles Latest Holdings Summary

Michael Glenn Miles currently owns a total of 1 stock. Michael Glenn Miles owns 5,000 shares of Cancer Genetics Inc (CGIX) as of January 31, 2019, with a value of $23,050.

Latest Holdings of Michael Glenn Miles

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGIX Cancer Genetics Inc 2019-01-31 5,000 4.61 23,050

Holding Weightings of Michael Glenn Miles


Michael Glenn Miles Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Glenn Miles has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 5,000 shares on January 31, 2019, which cost Michael Glenn Miles around $34,500.

Insider Trading History of Michael Glenn Miles

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Glenn Miles Trading Performance

GuruFocus tracks the stock performance after each of Michael Glenn Miles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Glenn Miles is -1.65%. GuruFocus also compares Michael Glenn Miles's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Glenn Miles within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Glenn Miles's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Glenn Miles

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 6.33 -1.65 -43.6 -42.23 -25.85
Relative Return to S&P 500(%) 2.65 -9.77 -53.82 -61.51 -43.07

Michael Glenn Miles Ownership Network

Ownership Network List of Michael Glenn Miles

No Data

Ownership Network Relation of Michael Glenn Miles


Michael Glenn Miles Owned Company Details

What does Cancer Genetics Inc do?

Who are the key executives at Cancer Genetics Inc?

Michael Glenn Miles is the Chief Financial Officer of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Executive Officer John A Roberts , and EVP Precision Medicine William Lansing Finger .

Cancer Genetics Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cancer Genetics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cancer Genetics Inc Insider Transactions

No Available Data

Michael Glenn Miles Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Glenn Miles. You might contact Michael Glenn Miles via mailing address: C/o Cancer Genetics Inc., 201 Route 17 North, 2nd Floor, Rutherford Nj 07070.

Discussions on Michael Glenn Miles

No discussions yet.